Prothena Corp Public (PRTA) Receivables - Other (2012 - 2015)
Prothena Corp Public's (PRTA) quarterly Receivables - Other came in at $30000.0 in Q1 2015, down 34.78% year-on-year from $46000.0 in Q1 2014, and little changed quarter-over-quarter from $30000.0 in Q4 2014.
Prothena Corp Public (PRTA) Receivables - Other (2012 - 2015) Analysis & Trends
Prothena Corp Public's Receivables - Other history runs 4 years deep, the most recent figure standing at $30000.0 for Q1 2015.
- On a quarterly basis, Receivables - Other fell 34.78% year-over-year to $30000.0 in Q1 2015; TTM through Mar 2015 was $30000.0, a 34.78% decrease from a year earlier, with the FY2014 full-year figure at $30000.0, down 48.28% from the prior year.
- Receivables - Other steadied at $30000.0 in Q1 2015 per PRTA's latest filing, from $30000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $261000.0 in Q1 2013 and bottomed at $30000.0 in Q4 2014.
- The 4-year median for Receivables - Other is $54500.0 (2013), against an average of $89500.0.
- Biggest YoY gain for Receivables - Other was 70.37% in 2014; the steepest drop was 82.38% in 2014.
- Year by year, Receivables - Other stood at $223000.0 in 2012, then sank by 73.99% to $58000.0 in 2013, then tumbled by 48.28% to $30000.0 in 2014, then changed by 0.0% to $30000.0 in 2015.
- Per Business Quant, the three latest PRTA Receivables - Other figures stand at $30000.0 (Q1 2015), $30000.0 (Q4 2014), and $92000.0 (Q3 2014).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 30,000.00 |
| Mar 31, 2015 | 30,000.00 |
| Dec 31, 2014 | 30,000.00 |
| Dec 31, 2014 | 30,000.00 |
| Sep 30, 2014 | 92,000.00 |
| Sep 30, 2014 | 92,000.00 |
| Jun 30, 2014 | 46,000.00 |
| Jun 30, 2014 | 46,000.00 |
| Mar 31, 2014 | 46,000.00 |
| Mar 31, 2014 | 46,000.00 |
| Dec 31, 2013 | 58,000.00 |
| Dec 31, 2013 | 58,000.00 |
| Sep 30, 2013 | 54,000.00 |
| Sep 30, 2013 | 54,000.00 |
| Jun 30, 2013 | 55,000.00 |
| Jun 30, 2013 | 55,000.00 |
| Mar 31, 2013 | 261,000.00 |
| Mar 31, 2013 | 261,000.00 |
| Dec 31, 2012 | 223,000.00 |
| Dec 31, 2012 | 223,000.00 |